Shares of MediPharm Labs Corp. (TSE:LABS – Get Free Report) reached a new 52-week low on Monday . The stock traded as low as C$0.06 and last traded at C$0.06, with a volume of 25262 shares. The stock had previously closed at C$0.07.
MediPharm Labs Price Performance
The stock has a market cap of C$27.35 million, a PE ratio of -2.17 and a beta of 0.06. The company has a debt-to-equity ratio of 1.45, a current ratio of 3.21 and a quick ratio of 3.10. The company has a 50 day moving average price of C$0.07 and a two-hundred day moving average price of C$0.07.
MediPharm Labs (TSE:LABS – Get Free Report) last released its quarterly earnings data on Thursday, November 13th. The company reported C($0.01) EPS for the quarter. MediPharm Labs had a negative net margin of 30.56% and a negative return on equity of 24.41%. The business had revenue of C$11.45 million for the quarter. Analysts expect that MediPharm Labs Corp. will post -0.04 EPS for the current year.
About MediPharm Labs
MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4.
Recommended Stories
- Five stocks we like better than MediPharm Labs
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Market Momentum: 3 Stocks Poised for Major Breakouts
- How Technical Indicators Can Help You Find Oversold Stocks
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- 3 Small Caps With Big Return Potential
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
